I agree that this site is using cookies. You can find further informations here.
X
Ramgopal, Moti
101  results:
Search for persons X
?
1

Safety of teropavimab and zinlirvimab with lenacapavir once..:

Eron, Joseph J ; Little, Susan J ; Crofoot, Gordon...
The Lancet HIV.  11 (2024)  3 - p. e146-e155 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Triple Threat: Triple Pathogen Endocarditis:

Gonzalez, Jessica M ; Lowenhaar, Gabriel ; Ramgopal, Moti.
Cureus.  , 2023
Link: https://doi.org/10.7759/..
 
?
3

Sustained Virologic Suppression With Dolutegravir/Lamivudin..:

Rolle, Charlotte-Paige ; Berhe, Mezgebe ; Singh, Tulika...
Open Forum Infectious Diseases.  10 (2023)  3 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
4

1985. A Prospective, Randomized Trial to Assess a Protease ..:

Short, William R ; Ramgopal, Moti ; Hagins, Debbie P...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
5

Molnupiravir for the treatment of COVID-19 in immunocomprom..:

Johnson, Matthew G. ; Strizki, Julie M. ; Brown, Michelle L....
Infection.  51 (2023)  5 - p. 1273-1284 , 2023
Link: https://doi.org/10.1007/..
 
?
6

Ibrutinib for Hospitalized Adults With Severe Coronavirus D..:

Coutre, Steven E ; Barnett, Christopher ; Osiyemi, Olayemi...
Open Forum Infectious Diseases.  9 (2022)  5 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
7

Utility and Impact of the Implementation of Same-Day, Self-..:

Short, Duncan ; Fredericksen, Rob J. ; Crane, Heidi M....
AIDS and Behavior.  26 (2022)  7 - p. 2409-2424 , 2022
Link: https://doi.org/10.1007/..
 
?
8

1586. Phase 3/3b Experience with Long-Acting Cabotegravir a..:

Patel, Parul ; Elliot, Emilie ; D'Amico, Ronald...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
9

1154. Safety, Tolerability, and Viral Pharmacodynamics of t..:

Gupta, Anil K ; Perez-Rodríguez, Maria Teresa ; Gonzalez-Rojas, Yaneicy...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
10

Proactive strategies to optimize engagement of Black, Hispa..:

Cespedes, Michelle ; Das, Moupali ; Hojilla, J. Carlo...
PLOS ONE.  17 (2022)  6 - p. e0267780 , 2022
Link: https://doi.org/10.1371/..
 
?
11

1251. 5-year outcomes of bictegravir/emtricitabine/tenofovi..:

Ramgopal, Moti ; Wurapa, Anson ; Baumgarten, Axel...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
12

Risk Factors for Suboptimal Adherence Identified by Patient..:

Short, Duncan ; Wang, Xueqi ; Suri, Shivali...
Patient Preference and Adherence.  16 (2022)  - p. 2461-2472 , 2022
Link: https://doi.org/10.2147/..
 
?
13

854. Long-term Outcomes of Participants on F/TAF for Pre-Ex..:

Ramgopal, Moti ; Ruane, Peter ; Shao, Yongwu...
Open Forum Infectious Diseases.  8 (2021)  Supplement_1 - p. S517-S518 , 2021
Link: https://doi.org/10.1093/..
 
?
14

Dolutegravir/lamivudine as a first-line regimen in a test-a..:

Rolle, Charlotte-Paige ; Berhe, Mezgebe ; Singh, Tulika...
AIDS.  35 (2021)  12 - p. 1957-1965 , 2021
Link: https://doi.org/10.1097/..
 
?
15

New Proteomic Signatures to Distinguish Between Zika and De..:

Allgoewer, Kristina ; Maity, Shuvadeep ; Zhao, Alice...
Molecular & Cellular Proteomics.  20 (2021)  - p. 100052 , 2021
Link: https://doi.org/10.1016/..
 
1-15